Journal of Cancer Research and Therapeutics Close
 

Figure 4: CD44+/CD24 cells were treated with Notch1 siRNA-2. (a) The protein expressions of Notch1 and ALDH1A in CD44+/CD24 cells treated with siRNA-4 and control siRNAs were analyzed by western blot (left) and gray scale scanning (right). (b) Spheres formed by CD44+/CD24 cells treated with siRNA-4 and control siRNAs. (c) Quantitative analysis of sphere-forming efficiency (left) and sphere numbers (right) formed from CD44+/CD24 cells treated with siRNA-4 and control siRNAs. (d) Cell proliferation of CD44+/CD24 cells treated with different siRNAs was detected by CCK-8

Figure 4: CD44<sup>+</sup>/CD24<sup>−</sup> cells were treated with Notch1 siRNA-2. (a) The protein expressions of Notch1 and ALDH1A in CD44<sup>+</sup>/CD24<sup>−</sup> cells treated with siRNA-4 and control siRNAs were analyzed by western blot (left) and gray scale scanning (right). (b) Spheres formed by CD44<sup>+</sup>/CD24<sup>−</sup> cells treated with siRNA-4 and control siRNAs. (c) Quantitative analysis of sphere-forming efficiency (left) and sphere numbers (right) formed from CD44<sup>+</sup>/CD24<sup>−</sup> cells treated with siRNA-4 and control siRNAs. (d) Cell proliferation of CD44<sup>+</sup>/CD24<sup>−</sup> cells treated with different siRNAs was detected by CCK-8